Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar

SARS-CoV-2 Omicron BA.1 and BA.2 subvariants are genetically divergent. We conducted a matched, test-negative, case-control study to estimate duration of protection of the second and third/booster doses of mRNA COVID-19 vaccines against BA.1 and BA.2 infections in Qatar. BNT162b2 effectiveness was h...

Descripción completa

Detalles Bibliográficos
Autores principales: Chemaitelly, Hiam, Ayoub, Houssein H., AlMukdad, Sawsan, Coyle, Peter, Tang, Patrick, Yassine, Hadi M., Al-Khatib, Hebah A., Smatti, Maria K., Hasan, Mohammad R., Al-Kanaani, Zaina, Al-Kuwari, Einas, Jeremijenko, Andrew, Kaleeckal, Anvar Hassan, Latif, Ali Nizar, Shaik, Riyazuddin Mohammad, Abdul-Rahim, Hanan F., Nasrallah, Gheyath K., Al-Kuwari, Mohamed Ghaith, Butt, Adeel A., Al-Romaihi, Hamad Eid, Al-Thani, Mohamed H., Al-Khal, Abdullatif, Bertollini, Roberto, Abu-Raddad, Laith J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163167/
https://www.ncbi.nlm.nih.gov/pubmed/35654888
http://dx.doi.org/10.1038/s41467-022-30895-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163167/
https://www.ncbi.nlm.nih.gov/pubmed/35654888
http://dx.doi.org/10.1038/s41467-022-30895-3

Ejemplares similares